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 Insulin-stimulated glucose uptake is a vital physiological process, which requires 
the translocation and fusion of insulin sensitive glucose transporter (GLUT4) vesicles 
from intracellular pools to the plasma membrane.  Previous studies have implicated 
cortical actin reorganization in GLUT4-mediated glucose uptake.  Not much is known, 
however, about how cortical actin is reorganized to allow GLUT4 vesicle fusion to the 
plasma membrane.  A recent study found that myosin II is necessary for insulin-
stimulated glucose uptake and implicated myosin II activity in cortical actin 
reorganization.  Our study further examined the role of myosin II in insulin-stimulated 
glucose uptake.  We found that myosin II associates with GLUT4 vesicles upon insulin 
stimulation.  This study also found that myosin II is necessary for proper GLUT4 vesicle 
fusion and activation.  This study is the first to demonstrate the dual role myosin II plays 
in GLUT4 vesicle fusion and activation during insulin-stimulated glucose uptake.  Our 
results provide further understanding into cellular and molecular mechanisms necessary 
for proper glucose uptake. 
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CHAPTER I 
 
INTRODUCTION 
 
 
Once a disease only associated with a small percentage of the juvenile and elderly 
subpopulations, diabetes has become indiscriminate and affects individuals of every age, 
race, gender and socioeconomic group. 
Because diabetes has begun to affect such a large and diverse group of people, the 
need to understand its pathology on the physiological, cellular, molecular, and genetic 
levels has become more urgent.  The knowledge attained through these studies can then 
lead to the development of preventative measures, early detection and therapeutic 
treatments. 
Type 1 Diabetes and Type II Diabetes 
Within the last fifty years, the prevalence of diabetes among Americans has 
increased.  In 1958, only 0.93% of the American population was diabetic (1).  Currently, 
120 million people worldwide are diabetic, 20.8 million of which are U. S. citizens (2,3).  
That is 7% of the U. S. population.  If the occurrence of diabetes continues to increase, 
there will be a projected 300 million diabetics worldwide by 2025 (3). 
There are two major types of diabetes:  Type I and Type II (1).  Type I diabetes or 
insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease in which the 
   2 
insulin-producing beta cells of the pancreas are destroyed (4).  Thus, Type I diabetics are 
required to take exogenous insulin (4).  
Type II diabetes or non-insulin-dependent diabetes mellitus (NIDDM) is the most 
common form of diabetes, affecting approximately 90% of diabetics (2, 4).  NIDDM is a 
result of insulin resistance, which leads to inefficient β-cell insulin production as well as 
the development of numerous health conditions, such as diabetic retinopathy (blindness), 
renal failure, hypertension, and myocardial infarctions (2, 4).  
What is Diabetes? 
With the increasing occurrence of diabetes among the world’s population, it is 
important to understand what diabetes is.  In general, diabetes is characterized by high 
serum glucose levels and insufficient insulin production, secretion, or activity (4).  In 
normal conditions, the rapid removal of glucose occurs when the hormone insulin signals 
adipocytes and skeletal muscle cells to clear excess serum glucose.  Without insulin-
stimulated glucose uptake, the majority of glucose remains in circulation for an extended 
period of time.  Consistently elevated serum glucose levels lead to insulin resistance. 
Understanding NIDDM 
 Before the onset of NIDDM, individuals first experience insulin resistance.  
Insulin resistance results from an improper response of adipose tissue and skeletal muscle 
tissue to serum insulin leading to a decrease in glucose uptake (4).  If insulin resistance 
remains untreated, NIDDM can develop.  
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In order to develop effective treatments and early intervention and prevention 
methods, it is necessary to understand the underlying cellular and molecular mechanisms 
that result in the development of NIDDM. 
Understanding the insulin signaling pathway is central to understanding NIDDM.  
This pathway regulates many physiological processes such as glucose homeostasis, 
gluconeogenesis, glycogenesis and lipogenesis.  The insulin signaling pathway is also 
responsible for the majority of glucose uptake in skeletal muscle and adipose tissue.  
Impaired glucose uptake causes a host of problems that can lead to the development of 
NIDDM.  Thus, a complete understanding of the cellular and molecular mechanisms 
involved in the insulin signaling pathway is necessary.  Such understandings can lead to 
medicinal discoveries, which will prevent or treat conditions caused by elevated serum 
glucose levels. 
Insulin-Stimulated Glucose Uptake  
 Insulin signal transduction results in glucose uptake via the insulin-responsive 
glucose transporter, GLUT4.  GLUT4 vesicles translocate to the plasma membrane as a 
result of the activation of the insulin-signaling pathway.  GLUT4 is responsible for 
glucose uptake in insulin sensitive tissues such as adipose tissue and skeletal muscle. 
When serum glucose levels are high, insulin is secreted from the pancreas into the 
blood and insulin signaling begins.  Insulin binds to its receptor, resulting in a series of 
events, starting with the activation of the insulin receptor tyrosine kinase via 
autophosphorylation.  The receptor tyrosine kinase then phosphorylates the insulin 
receptor substrate (IRS), which recruits and activates phosphatidylinositol-3-kinase (PI3 
   4 
kinase).  PI3 kinase activates both the serine/threonine protein kinase (Akt/PKB) and 
protein kinase C.  The activation of these kinases leads to the translocation of GLUT4 
vesicles from intracellular pools to the plasma membrane (Fig. 1) (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GLUT4 Vesicle Trafficking and Actin 
Previous studies have shown that there is a redistribution of GLUT4 vesicles from 
a perinuclear region (intracellular pools) to the plasma membrane when adipocytes are 
stimulated with insulin (6).  This translocation results from the interaction of GLUT4 
Figu
Figure 1:  Schematic of Insulin-Stimulated Glucose Uptake.  
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vesicles with the network of actin microfilaments that forms the cytoskeleton (7).  In 
brief, GLUT4 vesicles are translocated to the plasma membrane along actin tracks (8, 9). 
Once GLUT4 vesicles translocate to the plasma membrane, GLUT4 vesicles must 
fuse with the plasma membrane in order for glucose uptake to occur (10).  Beneath the 
plasma membrane, there is a layer of cortical filamentous actin (F-actin) (11).  Studies 
have found that cortical actin must undergo dynamic reorganization for optimal glucose 
uptake to occur (11).  Both disruption and stabilization of the cortical actin layer results 
in impaired glucose uptake (11).  These findings indicate that actin reorganization plays 
an important regulatory role in insulin-stimulated glucose uptake.  In addition, this study 
also found that the reorganization of cortical actin in adipocytes is the result of insulin 
stimulation (11).  Because cortical actin reorganization is insulin-dependent, it may play 
an important role in proper insulin-stimulated glucose uptake. 
In addition to its role in insulin-stimulated glucose uptake, actin plays a role in 
vesicle docking and fusion.  Studies have described cortical actin as a barrier, which can 
inhibit vesicle docking and fusion (9).   In order for vesicles to fuse to the plasma 
membrane, there must be disassembly of cortical filamentous actin (32, 33).  Once 
cortical actin is reorganized, vesicles are able to gain access to their proper docking and 
fusion sites at the plasma membrane (9).  This has been demonstrated for GLUT4 
vesicles.  Previous studies have found cortical actin must be remodeled before GLUT4 
vesicles can fuse to the plasma membrane (11).  Currently, the mechanism for actin 
reorganization is still not well understood. 
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GLUT4 Intrinsic Activity 
After fusion, GLUT4 must subsequently be activated before glucose uptake can 
occur (22).  In muscle cells, studies have shown that p38 mitogen-activated protein 
kinase (p38 MAPK) of the MAPK pathway is necessary for complete GLUT4 activity 
(12, 22, 23).  In addition, p44/p42 mitogen-activated protein kinase (p44/p42 MAPK) 
was found to increase GLUT4 activity in adipocytes (17). The precise interaction 
between p38 MAPK or p44/p42 MAPK and GLUT4 is still unknown, but studies have 
suggested that the increased GLUT4 activity is due to either the interaction of an 
activator ligand with GLUT4 (Fig. 2B) or the removal of an inhibitory ligand (Fig. 2A) 
from GLUT4 (12).  It is possible that cytoskeletal elements could play a role in the up-
regulation of GLUT4 activity by hindering p38 MAPK, p44/p42 MAPK or some other 
protein from accessing membrane-bound GLUT4. 
Actin and Myosin 
 GLUT4 vesicle trafficking and membrane fusion events require actin 
reorganization (6, 11, 24, 25).  It is uncertain how actin is reorganized during these 
events, especially during membrane fusion.  However, actin reorganization is well 
characterized in muscle cells.  In muscle movement, myosin II is necessary for actin 
contraction (13).  Studies have shown that myosin II plays a necessary role in actin 
contraction of non-muscle cells for processes such as cell motility, cytokinesis, cellular 
morphology, vesicle transport and exocytosis (14, 15, 16).  Thus, it is possible that 
myosin II may be responsible for the cortical F-actin reorganization required for GLUT4 
vesicle fusion in adipocytes. 
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A 
B 
Figure 2:  Schematic of the Putative GLUT4 Activation by MAPK.  (A) GLUT4 activation model 
based on the removal of inhibitory protein.  The inhibitory protein is represented as an (I).  (B) 
GLUT4 activation model based on the association of an activator protein.  The activator protein is 
represented as an (A).  
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Myosin II (conventional myosin) is a hexameric protein consisting of two heavy 
chains, two essential light chains (ELCs) and two regulatory light chains (RLCs) (15).  
Myosin II is responsible for the ATP-dependent contraction of actin filaments in skeletal 
muscle cells and is arranged in an orderly and stable configuration (27).  There are 
several heavy chain isoforms of myosin II.  Most vertebrates express two isoforms of 
myosin II, myosin IIA and myosin IIB.  The expression and localization of each isoform 
are dependant upon cell type (15).  The specific functions of each isoform are not yet 
clear due to their diverse distribution and dynamic localization (15).   However, in simple 
eukaryotes such as Dictyostelium, Acanthamoeba, and Saccharomyces, myosin II has 
been shown to play an important role in cytokinesis, cell locomotion, and maintenance of 
cell cortical rigidity (15, 26). 
Before myosin II can regulate cellular processes, myosin II must first be activated.    
Activation of myosin II occurs via phosphorylation of the RLCs of myosin II (15).  A 
kinase responsible for the phosphorylation of the RLCs of myosin II is myosin light chain 
kinase (MLCK), which activates myosin II (15). 
Role of Myosin II in Insulin-Stimulated Glucose Uptake 
Recently, our lab has shown that myosin II is involved in insulin-stimulated 
glucose uptake in adipocytes.  Inhibition of myosin II with blebbistatin (a specific 
inhibitor for non-muscle myosin II) was shown to cause a 66% reduction in insulin-
stimulated glucose uptake (8).  These results indicate that myosin II is important for 
insulin-stimulated glucose uptake.  We found that myosin II is not necessary for GLUT4 
translocation to the plasma membrane using immunofluorescence studies (Fig. 3).    In 
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untreated adipocytes, fluorescently labeled GLUT4 vesicles were found to be 
concentrated in the perinuclear region.  Upon insulin-stimulation, GLUT4 vesicles 
translocated to the plasma membrane.  In adipocytes treated with insulin + blebbistatin, 
GLUT4 vesicles were also shown to translocate to the plasma membrane in a similar 
manner as that seen in insulin-stimulated adipocytes (8).  Taken together, these findings 
suggest that myosin II is required for GLUT4-mediated glucose uptake but not for 
GLUT4 vesicle translocation. 
 
 
 
 
 
 
 
 
 
Our lab has also shown by indirect immunofluorescence that both isoforms of 
myosin II are expressed in adipocytes (8).  In unstimulated adipocytes, myosin IIA was 
expressed in the perinuclear region of the cells, while myosin IIB was primarily localized 
at the cell cortex (Fig. 4).  However, upon insulin stimulation, myosin IIA translocated to 
the cell cortex.  In contrast, the localization of myosin IIB remained unchanged after 
Figure 3:  Insulin-stimulated GLUT4 Translocation was not affected by Blebbistatin 
Treatment.  Adipocytes were treated according to the glucose uptake protocol as described 
in Materials and methods, and GLUT4 protein was visualized by indirect 
immunofluorescence using a GLUT4-specific antibody.  GLUT4 localization was assayed in 
whole cells in the basal condition and after stimulation with insulin in the presence and 
absence of 100µM blebbistatin.  The results are representative images from three independent 
experiments (9). 
Basal Insulin Insulin and Bleb 
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insulin treatment.  This suggests that the two isoforms may have different roles in glucose 
uptake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These findings suggest that myosin II plays a role in insulin-stimulated glucose 
uptake.  Further understanding of myosin II could lead to a possible explanation of how 
glucose uptake is regulated.  This study examined the role of myosin II as it relates to its 
functional relationship with GLUT4 vesicles.  Specifically, the role of myosin II in the 
Figure 4:  The Effect of Insulin Stimulation on Myosin II Localization in 
Adipocytes.  3T3-L1 adipocytes were treated according to the glucose uptake protocol 
as described in Materials and methods and the myosin II isoforms were visualized by 
immunofluorescence using either a myosin IIA or myosin IIB-specific antibody. 
Filamentous actin was visualized using Texas red–phalloidin. Myosin IIA, myosin IIB, 
and filamentous actin localization was analyzed in the basal condition and after 
stimulation with insulin in the presence and absence of 100 µM blebbistatin using 
confocal microscopy.  The results are representative images from three independent 
experiments (9). 
MyoIIB 
Actin 
MyoIIA 
Insulin and 
Bleb 
Insulin Basal 
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intrinsic activity of GLUT4 was investigated, as well as GLUT4 vesicle fusion and the 
physical interaction between GLUT4 vesicles and myosin II isoforms.  The fundamental 
hypothesis of this study is that myosin II is involved in the regulation of GLUT4 vesicle 
fusion and the activity of GLUT4 during insulin-stimulated glucose uptake in 3T3-L1 
adipocytes.
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CHAPTER II 
GOALS AND AIMS  
 
 
This study encompassed three different aims that examined the functional 
relationship between myosin II and GLUT4 vesicles during insulin-stimulated glucose 
uptake.   
Aim I:  Examination of a Putative Association between Myosin II and GLUT4  
  Vesicles. 
When adipocytes are stimulated with insulin, GLUT4 vesicles translocate to the 
plasma membrane (6).  In addition, insulin-stimulation leads to cortical actin 
reorganization, which allows the fusion of GLUT4 vesicles to the plasma membrane (9-
11).  Although previous studies have found insulin-stimulation is necessary for cortical 
actin reorganization and GLUT4 vesicle fusion, the mechanism for actin reorganization 
in membrane fusion events is still unknown. 
Actin is known to be reorganized by myosin II in both muscle and non-muscle 
contexts (13-16).  Since myosin II is known to contract (reorganize) actin, it is possible 
that myosin II is the mechanism by which actin is reorganized during insulin-stimulated 
glucose uptake, thereby allowing GLUT4 vesicle fusion to the plasma membrane in 
adipocytes.
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Our lab has shown that in the basal state myosin IIA is localized in the perinuclear 
region of the cell while myosin IIB is localized at the cell cortex. Upon insulin 
stimulation, myosin IIA relocalized to the cell cortex in adipocytes (8).  The localization 
of myosin IIA in the same region of the cell as GLUT4 vesicles suggests a possible 
association between the two.  This association could explain the highly specific 
coordinated action of actin reorganization at sites of GLUT4 vesicle fusion.  If GLUT4 
Figure 5:  Schematic of the Putative Physical Relationship between Myosin II and GLUT4 
Vesicles in Adipocytes. 
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vesicles and myosin IIA translocate to the plasma membrane together, myosin IIA could 
be responsible for the cortical actin reorganization necessary for vesicle fusion at the 
plasma membrane.  I hypothesized that there is an interaction between myosin IIA and 
GLUT4 vesicles (Fig. 5).  Immunoprecipitation assays were employed to examine a 
possible myosin II-GLUT4 vesicles interaction. 
Aim II:  Examination of the Role of Myosin II on the Intrinsic Activity of GLUT4. 
Upon insulin stimulation, GLUT4 vesicles translocate, dock and fuse to the 
plasma membrane.  In order for glucose uptake to occur, however, GLUT4 must also be 
activated.  Studies have suggested GLUT4 activity is up-regulated by its interaction with 
an activator ligand or by the removal of an inhibitory ligand from GLUT4 (12).  GLUT4 
activity can also be up-regulated by the MAPK pathway via p38 MAPK or p44/p42 
MAPK in muscle cells and adipocytes, respectively (12, 17, 22, 23). 
In addition, cortical actin is necessary for GLUT4 translocation and GLUT4-
mediated glucose uptake (11).  Dynamic cortical actin reorganization is necessary for 
proper vesicle docking and fusion (9).  Conversely, without dynamic reorganization, actin 
acts as a barrier to prevent vesicle docking and fusion.  These observations clearly 
suggest actin plays a role in GLUT4-mediated glucose uptake.  However, the mechanism 
of actin reorganization is still unclear. 
Taken together, these studies suggest a possible mechanism for actin 
reorganization.  The actin cytoskeleton could be acting as a barrier that may hinder p38 
MAPK, p44/p42 MAPK or another protein from accessing the membrane-bound GLUT4, 
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thereby preventing the activation of GLUT4.  Thus, actin reorganization may play a role 
in the up-regulation of GLUT4 activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Actin is reorganized by myosin II-mediated actin contraction (13-16).  Myosin II 
may be reorganizing actin to allow proper GLUT4 activation by a similar mechanism, 
facilitating GLUT4-mediated glucose uptake.  I hypothesized that myosin II is necessary 
for proper GLUT4 activation (Fig. 6).  Insulin-stimulated glucose uptake assays were 
performed to ascertain if inhibitors of myosin II impair the intrinsic activity of GLUT4. 
Figure 6:  Schematic for Putative Role of Myosin II on the Intrinsic Activity of 
GLUT4. 
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Aim III:  Examination of the Role of Myosin II in GLUT4 Vesicle Fusion to the  
  Plasma Membrane.   
Previous studies have shown that insulin-stimulation of adipocytes results in the 
reorganization of cortical actin (11).  This reorganization allows GLUT4 vesicles to fuse 
with the plasma membrane (9, 10).  The mechanism of actin reorganization, which allows 
vesicle fusion, is not well understood.  However, studies have found actin to be 
reorganized by myosin II in both muscle and non-muscle contexts (13, 14, 15, 16).  Thus, 
myosin II may be reorganizing actin to facilitate glucose uptake by allowing the fusion of 
GLUT4 vesicles to the plasma membrane during insulin-stimulated glucose uptake. 
Our lab began to investigate the mechanism of actin reorganization as it relates to 
insulin-stimulated glucose uptake.  Using a specific inhibitor for non-muscle myosin II 
blebbistatin, we found that inhibition of myosin II lead to inhibition of insulin-stimulated 
glucose uptake in 3T3-L1 adipocytes, but not GLUT4 translocation to the plasma 
membrane (8).  What is not known is whether myosin II is necessary for GLUT4 vesicle 
fusion with the plasma membrane.   
I hypothesized that myosin II is necessary for GLUT4 vesicle fusion (Fig. 7).  
Using confocal microscopy, I examined membrane-bound GLUT4 vesicles to determine 
if the inhibition of myosin II reduced the fusion of GLUT4 vesicles to the plasma 
membrane.  Membrane-bound GLUT4 vesicles were detectable on the cell surface by 
using a GLUT4 antibody targeting an epitope in the extracellular domain near the N-
terminus. 
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Figure 7:  The Role of Myosin II and GLUT4 Vesicle Fusion at the Plasma Membrane. 
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CHAPTER III 
MATERIALS AND METHODS 
Materials 
Dulbecco’s modified Eagles’s medium (DMEM) for tissue culture was purchased from 
Gibco (Grand Island, NY).  Insulin was obtained from Roche Diagnostics (Indianapolis, 
IN).  Dexamethasone, 3-isobutyl-1-methyl-xanthine, ML-7 (inhibitor of myosin light 
chain kinase) and myosin IIA antibody were purchased from Sigma (St.  Louis, MO). 
Blebbistatin (a specific inhibitor for non-muscle myosin II) was acquired from 
Calbiochem (San Diego, CA).  Myosin light chain (phospho S20) antibody was 
purchased from Abcam (Cambridge, MA).  GLUT4 antibodies (C-20 and N-20) were 
from Santa Cruz Biotechnology (Santa Cruz, CA).  Alexa Fluor 594 donkey anti-goat 
IgG and secondary goat anti-rabbit IgG were obtained from Molecular Probes (Eugene, 
OR). 
Methods 
Cell Culture 
3T3-L1 preadipocytes were cultured in DMEM and 10% calf serum (CS) to 
confluency.  After three days (day 0), preadipocytes were induced to differentiate with 
the addition of 0.5mM methylisobutylxanthine, 1µM dexamethasone, 1.7µM of insulin,
   19 
and 10% fetal bovine serum (FBS) in DMEM.  On day 3, media was removed and 
replaced with media containing 425nM insulin and 10% FBS in DMEM.  Cells were then 
maintained in DMEM containing 10% FBS and media was replaced every two days (18). 
Insulin Stimulation Assay 
Adipocytes were serum starved for 4 hours in DMEM and vehicle (0.1% DMSO) 
or inhibitor (100µM blebbistatin or 10µM ML-7).  Adipocytes were washed two times in 
Krebs-Ringer Phosphate (KRP) buffer (pH 7.4) containing 128mM NaCl, 4.7mM KCl, 
1.65mM CaCl2, 2.5mM MgSO4, and 5mM Na2HPO4 and then incubated in KRP buffer 
containing vehicle or various inhibitors as indicated at 37°C.  Insulin stimulation was 
performed at 37°C with 100nM insulin.  After a 20-minute incubation period, cells were 
washed twice in PBS at 4ºC.  Immediately following, adipocytes were lysed in a buffer 
containing 25 mM Hepes (pH 7.4), 1% Nonidet P-40, 100 mM NaCl, 2% (v/v) glycerol, 
5 mM NaF, 1 mM EDTA, 1 mM Na3VO4, 1 mMNaPPi, and protease and phosphatase 
inhibitor cocktails.  Lysates were gently agitated for 20 minutes at 4ºC and centrifuged 
(14000 g) for 20 minutes at 4ºC.  Laemmli sample buffer was added to lysates. 
Immunoprecipation Assay 
3T3-L1 preadipocytes were cultured on 10 cm plates, and induced to differentiate 
(as above).  Adipocytes were subjected to an insulin stimulation assay (as above).  After 
adipocytes were washed with cold PBS washes, they were fixed with 2% formaldehyde 
for 15 minutes and washed again with cold PBS three times.  A hypotonic buffer 
containing 20mM Tris (pH 7.5), 10mM NaCl, 3mM MgCl2, protease inhibitors, and 
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phosphatase inhibitors were used to lyse the cells.  Nonidet P 40 Substitute (NP-40) was 
added to cells at a concentration of 1:64.  The cells were then dounce homogenized (20 
strokes).  GLUT4 or myosin IIA was immunoprecipitated by using GLUT4 and myosin 
IIA-specific antibodies, respectively and agarose beads.  Immunoprecipitates were 
centrifuged at 2500g and washed with PBS three times at 4°C.  Laemmli sample buffer 
was added to the immunoprecipitates. 
Immunoblot Analysis 
Immunoprecipates or lysates were subjected to 10% or 15% SDS-PAGE, 
respectively. The gels were then transferred onto Immobilon-P membranes.  To reduce 
non-specific binding of the antibody, membranes were blocked by soaking in methanol 
for 10 seconds and dried at room temperature for 20 minutes.  After blocking, membranes 
of immunoprecipates were incubated in GLUT4 or myosin IIA primary antibodies.  
Membranes were incubated in myosin II RLC or myosin II p-RLC primary antibodies.  
Membranes were then incubated in secondary antibodies and visualized by enhanced 
chemiluminescent (ECL) reagents (18). 
Four Minute Glucose Uptake Assay 
3T3-L1 preadipocytes were cultured to confluence and induced to differentiate 
(see MATERIALS AND METHODS) in 6-well plates.  Differentiated adipocytes (day 8-
12) were serum-starved for approximately 4 hours in DMEM.  After the 4-hour 
starvation, adipocytes were washed two times in KRP buffer and then incubated in KRP 
buffer containing vehicle or various inhibitors as indicated at 37°C.  Vehicle (0.1% 
DMSO), 100nM insulin, or 100nM insulin and inhibitor (100µM blebbistatin or 10µM 
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ML-7) was added to respective well at 20-second intervals.  Immediately following, 
[
14
C]2-deoxy-D-glucose (0.1µCi/well) and 5mM glucose was added to each well at 20-
second intervals.  Each well was washed twice with phosphate buffered saline (PBS) at 
4°C and then lysed with 1mL of a 0.5M NaOH and 0.1% SDS solution.  Radio-labeled 
glucose uptake was quantified as disintegrations per mg protein (18). 
Immunofluoresence Assay 
3T3-L1 preadipocytes were cultured on coverslips, and induced to differentiate 
(as described previously).  Fully differentiated adipocytes were serum starved and 
stimulated with insulin for 20 minutes (as described previously).   Immediately following, 
adipocytes were fixed with 3.7% formaldehyde and washed with PBS.  Adipocytes were 
then incubated for an hour with a GLUT4 antibody (1:100) targeting an epitope in the 
extracellular domain near the N-terminus.  Cells were washed 5 times in cold PBS for 5 
minutes.  Then adipocytes were incubated in the secondary antibody, anti-goat 
Alexaflour 594 for 45 minutes.  Cells were washed 5 times in cold PBS for 5 minutes.  
Finally, coverslips were mounted and viewed using an Olympus IX81 Motorized Inverted 
Confocal Microscope and FLUOVIEW FV500 software (8, 18). 
Statistical Analysis 
Quantification of Glucose Uptake Assays 
Data are expressed as means ± SEM.  The significance of differences between 
means, set at P < 0:05, was assessed by Microsoft Excel. 
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Quantification of Immunoblots 
Protein bands were quantified by densitometry using ImageQuant (version 5.2 for 
Windows) software. 
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CHAPTER IV 
RESULTS 
Aim I Results:  The Association between Myosin IIA and GLUT4 is Insulin  
  Dependent. 
 Cortical actin acts as a barrier that inhibits vesicle docking and fusion (9).  Studies 
have found that insulin stimulation leads to cortical actin reorganization, which allows 
GLUT4 vesicle fusion (9, 11).  Previous studies have shown that there is a redistribution 
of GLUT4 vesicles from a perinuclear region (intracellular pools) to the plasma 
membrane when adipocytes are stimulated with insulin (6).  Also in 3T3-L1 adipocytes, 
we found that myosin IIA also relocalized from a perinuclear region to the plasma 
membrane upon insulin stimulation (8).  The similar redistribution of myosin IIA and 
GLUT4 vesicles upon insulin stimulation suggests a possible association.  This 
association could explain the highly specific coordinated action of actin reorganization at 
sites of GLUT4 vesicle fusion.  The focus of this study was to determine if myosin IIA 
and GLUT4 vesicles are associated using immunoprecipation assays. 
 Fully-differentiated adipocytes were serum starved in DMEM for 4 hours in the 
presence of vehicle (0.1% DMSO), vehicle + insulin, insulin + 100µM blebbistatin (a 
myosin II-specific inhibitor) or insulin + 10µM ML-7 (a myosin light chain kinase 
inhibitor).  The Basal (0.1% DMSO) treatment and Insulin (0.1% DMSO and 100nM 
insulin) treatment serve as a control for insulin stimulation and for inhibitor effectiveness,
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 respectively.   The Bleb (100nM insulin + 100µM blebbistatin) and ML-7 (100nM 
insulin + 10µM ML-7) treatments were used to determine the role and mechanism of 
myosin II in insulin-stimulated glucose uptake.  Specifically, the insulin + blebbistatin 
treatment determined if myosin II has to be associated with actin in order to interact with 
GLUT4 vesicles interaction.  The insulin + ML-7 treatment determined if an association 
between myosin II and GLUT4 is dependant upon the phosphorylation of myosin II RLC.  
In addition, the insulin + ML-7 treatment provided insight into the necessary signaling 
mechanism for this event.   
After serum starvation, adipocytes were subjected to insulin stimulation assays 
and then treated according to the immunoprecipation protocol (see MATERIALS AND 
METHODS).  Vesicles were isolated by centrifugation.  Antibodies for myosin IIA or 
GLUT4 were used to immunoprecipitate myosin IIA or GLUT4 respectively.  
Immunoprecipitates were subjected to SDS-PAGE and immunoblotting (Fig. 8A and 8B). 
In unstimulated 3T3-L1 adipocytes, low levels of the GLUT4 protein associated 
with myosin IIA (Fig. 8A).  However, upon insulin stimulation, the association between 
GLUT4 protein and myosin II increased (Fig. 8A).  As in insulin stimulated cells, myosin 
IIA immunoprecipitates from both the insulin + blebbistatin and the insulin + ML-7 
treated cells showed a greater association between GLUT4 protein and myosin II than 
that to unstimulated cells, which resembled the results of the insulin treatment (Fig. 8A).  
To verify that the increase in GLUT4 was not owing to an increase in myosin IIA, 
myosin IIA immunoprecipitates were probed with myosin IIA.  All samples in all four 
conditions showed similar levels of myosin IIA protein (Fig. 8A).  Thus, any difference 
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in GLUT4 protein associated with myosin II is not due to increased myosin II, but rather 
an increase in the amount of GLUT4 associated with myosin II. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The GLUT4 immunoprecipitates verified the results of the myosin IIA 
immunoprecipitates (Fig. 8B).  Unstimulated cells showed low levels of myosin IIA 
associated with GLUT4 (Fig. 8B).  Once stimulated with insulin, the association between 
myosin IIA and with GLUT4 protein was increased (Fig. 8B).  In addition, the insulin + 
blebbistatin and the insulin + ML-7 treated GLUT4 immunoprecipitates showed a greater 
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Figure 8: The Association between Myosin IIA and GLUT4 is Insulin Dependent.  3T3-L1 
adipocytes were serum starved for 4 hours and then treated according to the insulin stimulation 
assay and immunoprecipitation protocol (as described previously in MATERIALS AND 
METHODS) in unstimulated (Basal), vehicle and insulin (Insulin), insulin and 100 µM 
blebbistatin (Bleb), or insulin and 10µM ML-7 conditions (ML-7).  Vesicles were isolated from 
lysates.  Protein was immunoprecipitated with (A) myosin IIA antibody or (B) GLUT4 antibody.  
All immunoprecipitates were then subjected to 15% SDS-PAGE and immunoblotting.  The 
results are representative of three independent experiments. 
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association between myosin IIA and GLUT4 proteins when compared to unstimulated 
samples (Fig. 8B).  Again, the results of both the insulin + blebbistatin and the insulin + 
ML-7 treated cells were similar to the Insulin treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9:  Insulin Simulates Phosphorylation of Myosin II Regulatory Light Chain.  
3T3-L1 Adipocytes were serum starved for 4 hours and then treated according to the insulin 
stimulation assay in unstimulated (Basal), Insulin, Blebbistatin, or ML-7 conditions.  (A) 
Whole cell lysates were prepared and subjected to 10% SDS-PAGE and then immunoblotted 
using either a phosphorylated myosin II regulatory light chain or myosin II regulatory light 
chain antibody.  (B) The signal was normalized to myosin II regulatory light chain by 
densitometry.  This is representative of three independent experiments. 
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Previous studies have implicated insulin signaling in increased myosin II 
regulatory light chain phosphorylation (21).  These studies also found that ML-7 was an 
effective inhibitor of MLCK (21).  To verify these findings, additional experiments were 
performed.  Whole cell lysates were subjected to 10% SDS-PAGE and probed with a 
myosin II p-RLC and a myosin II RLC antibody (Fig. 9A).  The signal was then 
normalized to myosin II regulatory light chain by densitometry (Fig. 9B). 
Upon insulin stimulation, the levels of phosphorylated myosin II regulatory light 
chain increased.  The insulin + blebbistatin treatment showed similar levels as that of the 
insulin treatment.  There was, however, a decrease in the levels of phosphorylated myosin 
II regulatory light chain in the ML-7 (insulin + ML-7) treatment.  This result indicates 
that ML-7 is an effective inhibitor of MLCK and that MLCK phosphorylates the RLC 
upon insulin stimulation.  
Aim II Results:  Proper Intrinsic Activity of GLUT4 Requires Myosin II Activity. 
 Previous studies have found that myosin II is required for GLUT4-mediated 
glucose uptake (8).  This could reflect a requirement of myosin II for GLUT4 vesicle 
fusion and/or GLUT4 activity.  In order to determine what role myosin II may have on 
GLUT4 intrinsic activity, fully mature 3T3-L1 adipocytes were serum starved in DMEM 
for 4 hours in unstimulated (Basal), Insulin, Bleb (insulin + blebbistatin), and ML-7 
(insulin + ML-7) treatments.   
Inhibitor treatments were used to determine the role and mechanism for myosin II 
in proper GLUT4 intrinsic activity.  The blebbistatin treatment specifically determined if 
the actin-myosin II association is necessary for proper GLUT4 intrinsic activity, while 
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the insulin + ML-7 treatment ascertained the kinase responsible for myosin II activation, 
which is required for proper GLUT4 intrinsic activity.  The insulin + ML-7 treatment also 
provided insight into the signaling mechanism necessary for proper GLUT4 intrinsic 
activity.  
After serum starvation, adipocytes were subjected to 4-minute glucose uptake 
assays (see MATERIALS AND METHODS) using [
14
C]2-deoxy-D-glucose.  Previous 
studies have shown that maximum GLUT4 translocation to the plasma membrane occurs 
between 10-14 minutes (7, 29).  Thus, the short 4-minute time period will only examine 
glucose uptake from embedded GLUT4 vesicles.  Our short time frame does not allow 
enough time for GLUT4 translocation to occur.   
Insulin-stimulated adipocytes showed a two-fold increase in glucose uptake over 
unstimulated adipocytes (Fig. 10). In contrast, the insulin + blebbistatin treated cells 
showed inhibition of insulin-stimulated glucose uptake by 68% (Fig. 10A).  To determine 
the signaling mechanism necessary for proper GLUT4 intrinsic activity as related to 
myosin II, additional assays were performed with the MLCK inhibitor, ML-7.  
Adipocytes treated with insulin + ML-7 showed an inhibition of glucose uptake by 22% 
(Fig. 10B) when compared to insulin-stimulated adipocytes. 
Additional experiments were performed to examine the phosphorylation of the 
myosin II regulatory light chain, which is a control for insulin and inhibitor effectiveness.  
Whole cell lysates were subjected to 10% SDS-PAGE and probed with a phosphorylated 
myosin II regulatory light chain and a myosin II regulatory light chain antibody (Fig. 
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11A).  Protein was normalized to total myosin II regulatory light chain by densitometry 
(Fig. 11B). 
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Figure 10:  Myosin II Increases the Intrinsic Activity of GLUT4 during Insulin-
Stimulated Glucose Uptake in 3T3-L1 Adipocytes.  Adipocytes were serum starved in 
DMEM for 4 hours and then treated according to the glucose uptake protocol (as 
previously described in MATERIALS AND METHODS) in the Basal, Insulin and Bleb 
(A) or ML-7 (B) conditions.  Adipocytes were then assayed for incorporated [
14
C]2-
deoxy-D-glucose.  The data are expressed as a percent of the vehicle control. Results are 
means ± standard error mean (SEM) of three independent experiments. 
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Immunoblotting analysis showed an increase of phosphorylation of the myosin II 
RLC upon insulin stimulation.  The Bleb (insulin + blebbistatin) treatment showed 
similar levels of phosphorylated myosin II regulatory light chain as the insulin treatment 
(data not shown).  The ML-7 (insulin + ML-7) treatment showed decreased 
Figure 11:  Insulin Stimulates Phosphorylation of Myosin II Regulatory Light Chain. 
3T3-L1 Adipocytes were serum starved for 4 hours and then treated according to the insulin 
stimulation assay (as previously described in MATERIALS AND METHODS) in Basal, 
Insulin and ML-7 conditions.  (A) Whole cell lysates were prepared, subjected to 10% SDS-
PAGE and then immunoblotted using either a phosphorylated myosin II regulatory light 
chain or myosin II regulatory light chain antibody.  (B) Immunoblots were quantified by 
densitometry.  Results are representative of three independent experiments. 
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phosphorylation of the myosin II RLC (Fig. 11A).  These findings indicate that ML-7 is 
an effective inhibitor of MLCK.  In addition, these experiments suggest that 
phosphorylation of myosin II RLC via MLCK is required for activation of GLUT4 by 
insulin stimulation. 
Aim III Results:  GLUT4 Vesicle Fusion with the Plasma Membrane Requires  
  Myosin II Activity. 
The translocation, docking and fusion of GLUT4 vesicles is what drives insulin-
stimulated glucose uptake in mature adipocytes.  In several cell types, myosin II has been 
found to be necessary in vesicle trafficking (16-21).  However, recent studies have found 
myosin II is not required for GLUT4 vesicle translocation, but is necessary for proper 
GLUT4-mediated glucose uptake (8).  What is not known is if myosin II is required for 
GLUT4 vesicle fusion with the plasma membrane. 
To examine if myosin II is required for GLUT4 vesicle fusion, confocal 
microscopy was used to visualize fusion of GLUT4 vesicles to the plasma membrane of 
adipocytes.  To this end, fully differentiated 3T3-L1 adipocytes were serum starved for 4 
hours in unstimulated (Basal), Insulin, Bleb, or ML-7 conditions.  The Bleb treatment 
will ascertain if an actin-myosin II interaction is necessary for GLUT4 vesicle fusion, 
whereas the ML-7 (insulin + ML-7) treatment will determine how myosin II is activated 
to aid in GLUT4 vesicle fusion. 
After serum starvation, adipocytes were subjected first to the insulin stimulation 
assay and then to an immunofluorescence assay (see MATERIALS AND METHODS) 
using a GLUT4 antibody targeting an epitope in the extracellular domain near the N-
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terminus.  In standard immunofluorescence assays, cells are permeablized with a 
detergent, such as Triton-X.  However, this study did not permeablize the plasma 
membrane since only the GLUT4 vesicles properly fused to the plasma membrane were 
being examined.  Properly fused GLUT4 vesicles will have the extracellular domain on 
the outside of the cell.  After adipocytes were probed with the antibody, they were then 
visualized by confocal microscopy.  Differential interference contrast (DIC) images of 
each treatment (Fig. 12 – panels E-H) were taken in addition to the confocal images to 
verify the presence of adipocytes. 
As expected, insulin-stimulated adipocytes showed a dramatic increase in fused 
GLUT4 vesicles when compared to unstimulated adipocytes (Fig. 12 – compare panel B 
to A).  This confirms previous studies, which found that GLUT4 vesicles relocalize to the 
plasma membrane upon insulin stimulation (6).  To determine if the myosin II- mediated 
cortical actin contraction is necessary for the fusion of GLUT4 vesicles to the plasma 
membrane, adipocytes were treated with insulin + blebbistatin.  The adipocytes treated 
with insulin + blebbistatin showed decreased levels of fused GLUT4 vesicles when 
compared to insulin-stimulated cells (Fig. 12 – compare panel C to B).  The insulin + 
ML-7 treatment was performed to provide insight into the signal mechanism required for 
myosin II activation during cortical actin contraction.  Adipocytes treated with insulin + 
ML-7 showed a substantial decrease in the level of properly fused GLUT4 vesicles when 
compared to adipocytes stimulated with insulin alone (Fig. 12 – compare panel D to B).  
However, the insulin + ML-7 treated adipocytes failed to inhibit GLUT4 vesicle fusion to 
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the same extent as adipocytes treated with insulin + blebbistatin (Fig. 12 – compare 
panels D to C).   
 
Figure 12:  Inhibition of Myosin II Activity Inhibits GLUT4 Vesicle Fusion with 
the Plasma Membrane.  Fully-matured 3T3-L1 adipocytes were serum starved in 
DMEM for 4 hours and then treated according to the immunofluorescence protocol (as 
described in MATERIALS AND METHODS).  Fused GLUT4 vesicles were visualized 
using a GLUT4-specific antibody targeting an epitope in the extracellular domain near 
the N-terminus. GLUT4 localization in adipocytes was examined in (A) the basal 
condition  and (B) after stimulation with insulin (C) in the presence of 100µM 
blebbistatin or (D)  10µM ML-7. Differential Interference Contrast (DIC) images of 
each treatment were taken as well (E-H).  The results are representative images from 
three independent experiments. 
Basal Insulin 
Insulin 
 
  Blebbistatin 
  +  
Insulin 
 
ML-7 
+ 
A B C D 
E F G H 
   34 
CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 
 
With the ever-increasing prevalence of type II diabetes worldwide, scientists are 
seeking to gain a comprehensive understanding of insulin-stimulated glucose uptake.  
The purpose of this study was to further examine a novel finding implicating myosin II in 
facilitating glucose uptake.  Specifically, this study examined the role of myosin II in 
GLUT4 activity and GLUT4 vesicle fusion. 
Aim I:  Examination of a Putative Association between Myosin II and GLUT4    
  Vesicles. 
Summary Review  
In insulin-stimulated glucose uptake, GLUT4 vesicles will translocate from a 
perinuclear region to the plasma membrane of insulin sensitive tissues such as adipose 
tissue.  The redistribution of GLUT4 vesicles upon insulin stimulation is the result of 
interactions between GLUT4 vesicles and actin microfilaments (7).  When GLUT4 
vesicles translocate to the membrane, they then must fuse with the plasma membrane.   
Previous studies have shown that there is a layer of cortical actin beneath the 
plasma membrane in adipocytes and that the cortical actin layer must be reorganized to 
allow vesicles to fuse with the plasma membrane (9, 11).  The mechanism of cortical 
actin remodeling is not well understood.  However, previous studies have found actin to 
be reorganized by myosin II (conventional myosin) in both muscle and non-muscle cell
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contexts (13 – 16).  In addition, studies found that myosin II-mediated cortical actin 
contraction is necessary for vesicle fusion in chromaffin cells (16). 
Previous studies have found that cortical actin will reorganize upon insulin 
stimulation, which is necessary for glucose uptake and/or vesicle fusion (9, 11).  Because 
of these findings, our lab sought to examine the mechanism of cortical actin 
reorganization in insulin-stimulated glucose uptake (9-11).  In addition, other studies 
have implicated myosin II in actin reorganization (13-16).  Based upon myosin II 
implication in actin reorganization, we examined myosin II to determine if it had a role in 
insulin-stimulated glucose uptake in 3T3-L1 adipocytes.  Our lab found that myosin II 
plays a role in GLUT4-mediated glucose uptake.   
Discussion of findings:  The association between myosin IIA and GLUT4 is insulin 
dependent 
  In previous studies, our lab found myosin IIA redistribution to mimic GLUT4 
vesicle localization and translocation upon insulin stimulation.  What was not known is 
whether GLUT4 vesicles and myosin IIA travel together to the plasma membrane.  
Through immunoprecipation assays, we determined that an association exists between 
GLUT4 vesicles and myosin IIA to allow simultaneous movement.  Our results indicated 
that GLUT4 vesicles and myosin IIA associate upon insulin-stimulation.  There was a 
greater association between GLUT4 and myosin IIA in insulin-stimulated cells when 
compared to the unstimulated cells. This, however, did not provide insight into how 
myosin II is associating with GLUT4 vesicles. 
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Myosin II is known to contract actin.  Thus, myosin IIA may associate with 
GLUT4 vesicles through an interaction with actin.  Previous studies have observed actin 
on transport vesicles, such as GLUT4 vesicles (28).  To determine how myosin IIA 
associates with GLUT4 vesicles, two inhibitors (blebbistatin and ML-7) were used in 
these immunoprecipation assays. 
Blebbistatin is a myosin II-specific inhibitor that impairs the physical interaction 
between myosin II and actin.  We found that blebbistatin did not significantly alter the 
level of myosin IIA associated with GLUT4 vesicles upon insulin stimulation.  Thus, 
there was a greater association between GLUT4 and myosin IIA in the insulin + 
blebbistatin treated cells than in unstimulated cells.  Taken together, our findings suggest 
that the association between myosin IIA and GLUT4 vesicles is not mediated by actin. 
ML-7 is an inhibitor of MLCK.  MLCK is a kinase that activates myosin II by 
phosphorylating the regulatory light chain of myosin II.  In the immunoprecipation 
assays, the insulin + ML-7 treatment provided insight into the necessary signaling 
mechanism for myosin IIA activation.  We found that ML-7 did not significantly alter the 
level of myosin IIA associated with GLUT4 vesicles upon insulin stimulation.  The 
insulin + ML-7 treated cells showed a greater association between GLUT4 and myosin II 
than that of unstimulated cells.  Thus, these results suggest that the insulin-stimulated 
association of myosin II with GLUT4 does not require myosin II activation by MLCK. 
In conclusion, the immunoprecipation assays found that an association between 
GLUT4 vesicles and myosin IIA occurs upon insulin stimulation.  However, this 
association is not due to myosin II-actin interactions or the activation of myosin II by 
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MLCK.  We are the first to show an association between myosin IIA and GLUT4 
vesicles upon insulin-stimulation.  Although novel, our findings are consistent with other 
studies that determined myosin IIA can bind to vesicles (30, 31). 
Also, the results of this study determined that the myosin IIA-GLUT4 vesicle 
association is not dependent upon myosin IIA interaction with actin.  These results must 
be further verified.  Previous studies have observed actin on GLUT4 vesicles (28).  
Logically, myosin IIA should be interacting with this actin on GLUT4 vesicles.  
However, upon verification of these results, this study suggests that myosin II may be 
able to interact with other proteins other than actin.  This finding would be consistent 
with other studies that have shown myosin II to interact with other proteins, such as p200, 
a peripheral membrane protein (31).   
Our study also found that the insulin dependent myosin IIA-GLUT4 vesicle 
association is not reliant upon myosin IIA activation by MLCK.  However, myosin II 
may still require activation.  Additional immunoprecipation assays should be performed 
to determine if other kinases are responsible for myosin IIA activation during this 
association event. 
Future studies 
 The results of this study suggest myosin IIA is associated with GLUT4 vesicles 
via another protein besides actin.  To provide further confirmation and credence to these 
findings, the next series of experiments performed should verify the results of this study.  
One suggestion is to perform immunoprecipation assays with isolated GLUT4 vesicles 
using an actin antibody.  Immunoprecipitates will then subjected to SDS-PAGE and 
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immunoblot analysis using actin, myosin IIA, and GLUT4 antibodies.  The results will 
further verify myosin IIA is associated with GLUT4 vesicles through another protein.  
Additional future studies should ascertain the identity of this protein.  
Aim II:  Examination of the Role of Myosin II on the Intrinsic Activity of GLUT4. 
Summary Review 
 Studies have found that dynamic actin reorganization is necessary for proper 
GLUT4-mediated glucose uptake (11).  Cortical actin must be reorganized to allow 
vesicle fusion (9). However, cortical actin could be acting as a barrier to other proteins 
such as those necessary to activate GLUT4 (9).  Previous studies have found GLUT4 
vesicles will translocate, dock and fuse to the plasma membrane upon insulin stimulation 
(7-10).  After GLUT4 vesicles fuse to the plasma membrane, GLUT4 must be activated 
in order for glucose uptake to occur (22).  The exact mechanism for GLUT4 activation is 
still unknown, but studies have suggested that GLUT4 activity is up-regulated by either 
the interaction of an activator ligand or the removal of an inhibitory ligand (12).   In 
addition, previous studies have found that two kinases, p38 MAPK and p44/p42 MAPK 
stimulated GLUT4 activity in skeletal muscle cells and adipocytes, respectively (12, 17, 
22, 23).  Because the actin cytoskeleton may be hindering proteins such as p38 MAPK 
and p44/p42 MAPK from proper access to embedded GLUT4, it is important to 
determine whether cortical actin reorganization facilitates GLUT4 activation. 
Discussion of findings:  Intrinsic activity of GLUT4 requires myosin II activity 
As with the previous aim, this aim examined the role myosin II may play in 
cortical actin reorganization in insulin-stimulated glucose uptake.  Specifically, we 
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determined if myosin II plays a role in the intrinsic activity of GLUT4.  To ascertain the 
role myosin II may play in the intrinsic activity of GLUT4 to transport glucose, we 
performed 4-minute insulin-stimulated glucose uptake assays using [
14
C]2-deoxy-D-
glucose.  The 4-minute time frame was utilized in order to examine only the membrane-
embedded GLUT4.  Previous studies have found maximum GLUT4 translocation to 
occur between 10-14 minutes (7, 29).  By performing glucose uptake experiments during 
this short time frame, we are able to eliminate glucose uptake due to GLUT4 translocated 
from intracellular pools.  
 The focus of this study was to examine the possible role of myosin II on the 
intrinsic activity of GLUT4 during insulin-stimulated glucose uptake.  To ascertain the 
role of myosin II, two inhibitors (blebbistatin and ML-7) were used in this assay.   
We found that blebbistatin inhibited glucose uptake by 68% when compared to 
insulin-stimulated cells.  This indicates that myosin II-mediated actin contraction is 
necessary for the optimal intrinsic activity of previously embedded GLUT4 vesicles to 
transfer glucose into adipocytes.  Thus, myosin II activity plays a role in cortical actin 
reorganization by possibly allowing essential proteins to interact with GLUT4, which will 
simulate GLUT4 activity. 
We found that ML-7 inhibited glucose uptake by 22% when compared to insulin-
stimulated cells.  This result provides insight into the necessary signaling mechanism for 
the activation of myosin II.  MLCK is necessary for the activation of myosin II during 
insulin-stimulated glucose uptake. 
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When compared to the results of the blebbistatin treatment, the ML-7 (insulin + 
ML-7) treatment results did not provide a comparable inhibitory effect.  There are a 
variety of explanations for this effect.  One explanation may be due to other kinases.  
Since MLCK activity is inhibited, other kinases may be compensating for MLCK by 
phosphorylating the RLC.  Another explanation for ML-7 smaller inhibitory effect could 
involve the time period of myosin II activation.  Myosin II may have been activated prior 
to the end of the 4-minute time period.  Regardless, this inhibition indicates that MLCK 
is a necessary signaling molecule to activate myosin II, which allows optimal GLUT4-
mediated glucose uptake. 
 The results of this study supported previous findings.  We verified that glucose 
uptake is increased in insulin-stimulated cells when compared to unstimulated cells 
during the short 4-minute time period.  This confirms that insulin-stimulation causes an 
increase in the intrinsic activity of embedded GLUT4.  Under normal physiological 
conditions, low levels of GLUT4 are always present at the plasma membrane regardless 
of an insulin signal.  The amount of GLUT4 is determined by the insulin signaling.  If 
serum glucose levels are normal, additional insulin will not be secreted and most GLUT4 
vesicles will be sequestered in the perinuclear region of the cell.  However, it is important 
to remember that GLUT4 is still present at the plasma membrane.  Since, GLUT4 must 
be activated after it fuses with the plasma membrane, there can actually be fused GLUT4 
vesicles that are not actively transporting glucose into adipose or skeletal muscle tissue. 
In conclusion, myosin II-mediated cortical actin reorganization is necessary for 
the intrinsic activity of GLUT4 vesicles to allow insulin-stimulated glucose uptake in 
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3T3-L1 adipocytes.  Our study is the first to find that myosin II is necessary for the 
upregulation of GLUT4 activity. 
This study also found that myosin II activation is a result of its phosphorylation 
by MLCK.  Thus, myosin II requires activation by MLCK for full upregulation of 
GLUT4 intrinsic activity.  Our findings are the first to provide insight into the necessary 
signaling mechanism of GLUT4 activation via of myosin II activation.  A complete 
signaling pathway for the activation of myosin II to allow GLUT4 activation will provide 
new understanding to impaired insulin sensitivity. 
Future studies 
   While cell lines such as 3T3-L1 adipocytes are very useful, they may not function 
exactly like a living organism.  Thus, the next set of experiments should be an in vivo 
study using cells from myosin IIA knockout mice.  In vivo glucose uptake and insulin 
stimulation assays can provide insight into the role myosin II plays during insulin-
stimulated glucose uptake in a living model.  
Aim III:  Examination of the Role of Myosin II in GLUT4 Vesicle Fusion to the 
Plasma Membrane. 
Summary Review  
Previous studies have determined adipocytes contain a F-actin layer beneath the 
plasma membrane in adipocytes, which must be reorganized to allow vesicle fusion with 
the plasma membrane (9, 11).  However, this mechanism of cortical actin reorganization 
is not well understood, but studies have found actin to be reorganized by myosin II in 
both muscle and non-muscle cell contexts (13 – 16).  In addition, our lab found that 
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myosin II was necessary for proper insulin-stimulated glucose uptake, but not required 
for GLUT4 vesicle translocation to the plasma membrane (8). We also found that the 
inhibition of myosin II did not affect the phosphorylation of Akt, which is a distal event 
in the insulin signaling pathway.  These findings suggest that myosin II is involved in the 
docking and/or fusion of GLUT4 vesicles to the plasma membrane.   
Discussion of findings:  GLUT4 vesicle fusion with the plasma membrane requires 
myosin II activity 
The last aim of this study was to determine if myosin II activity was necessary for 
the fusion of GLUT4 vesicles to the plasma membrane.  Confocal microscopy was used 
to examine the role of myosin II in proper GLUT4 vesicle fusion.  To ensure that only 
fused GLUT4 vesicles were being examined, no Triton-X was used to prepare cells for 
the confocal study.  Triton-X is a detergent that permeablizes cells to allow antibodies 
access to intracellular proteins.  The antibody employed in this study specifically targets 
the extracellular domain near the N-terminus of GLUT4.  The extracellular domain of 
GLUT4 will be on the outside of the cell if GLUT4 vesicles have properly fused with the 
plasma membrane.  
In all physiological states, there are always some GLUT4 vesicles embedded in 
the membrane, but most are sequestered in intracellular pools within the cell when they 
are not required to transfer glucose.  Insulin-stimulation of adipocytes will cause 
perinuclear GLUT4 vesicles to translocate, dock, and fuse to the plasma membrane.  The 
results of the insulin treatment confirmed this fact.   Our study verified that the 
concentration of fused GLUT4 vesicles will increase upon insulin-stimulation (6, 7, 29).     
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The last aim of this study was to determine if myosin II activity was necessary for 
the fusion of GLUT4 vesicles to the plasma membrane.  To determine the role of myosin 
II, two inhibitors (blebbistatin and ML-7) were used. 
The blebbistatin treatment was use to establish if the physical interaction between 
myosin II and actin was necessary to allow the fusion of GLUT4 vesicles.  The results 
showed GLUT4 vesicle fusion was impaired when myosin II was inhibited by the 
blebbistatin treatment.    This finding suggests that myosin II is involved in the 
mechanism necessary to reorganize cortical actin to allow GLUT4 vesicle fusion.  
  The ML-7 (insulin + ML-7) treatment was used to determine how myosin II 
must be activated in order to interact with cortical actin.  The results of this experiment 
found a significant reduction in GLUT4 vesicle fusion to the plasma membrane when 
MLCK was inhibited. This finding indicates that MLCK plays a key role in myosin II 
activation, and thus GLUT4 vesicle fusion with the plasma membrane. 
In conclusion, our study indicates that myosin II activity is necessary for proper 
GLUT4 vesicle fusion to the plasma membrane.  Our findings are the first to describe a 
role for myosin II activity in GLUT4 vesicle fusion.  This study has provided insight into 
a necessary structural event for GLUT4 vesicle fusion.  Some studies have suggested that 
myosin II might play a necessary role in vesicle fusion (16), but our findings are the first 
to actually demonstrate that myosin II plays a role in GLUT4 vesicle fusion.  In addition, 
this study suggests that GLUT4 vesicle fusion requires the activation of myosin II by 
MLCK.  Our findings are the first to provide insight into the necessary signaling 
mechanism of myosin II activation for GLUT4 vesicle fusion.  Additional studies can 
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now be performed to ascertain upstream signaling events for the activation of myosin II.  
Characterization of the pathway for GLUT4 vesicle fusion via myosin II activation will 
provide additional insight into impaired insulin sensitivity.   
Future Studies 
 Previous studies performed in our lab found that myosin IIA will relocalize to the 
plasma membrane upon insulin-stimulation.  Thus, we believe myosin IIA is the isoform 
responsible for GLUT4 vesicle fusion.  However, our study also found that myosin IIB is 
localized at the plasma membrane in unstimulated and stimulated conditions.  The next 
series of studies should elucidate the roles of each isoform in GLUT4 vesicle fusion.  
This study will examine if one isoform is responsible for GLUT4 vesicle fusion or if both 
myosin II isoforms play a role in GLUT4 vesicle fusion.   To ascertain this information, 
confocal studies will be performed in in vitro (3T3-L1 adipocyte cell line) and cells from 
myosin IIA or myosin IIB knockout mice. 
Conclusions 
 Insulin-stimulated glucose uptake is a highly regulated physiological process.  
Previous studies have found that dynamic cortical actin reorganization is necessary for 
optimal GLUT4 vesicle fusion as well as GLUT4-mediated glucose uptake.  Until 
recently, the dynamic remodeling of cortical actin was not well understood.  In this and 
previous studies, our lab has examined the role of myosin II during insulin-stimulated 
glucose uptake.  Our findings implicate myosin II as the mechanical mechanism 
responsible for cortical actin reorganization. 
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This study found that myosin IIA associates with GLUT4 vesicles upon insulin 
stimulation.  However, this association is not due to the myosin II-actin interactions or 
the activation of myosin II by MLCK.  Although, the activation of myosin II may result 
from other kinases, further studies possibly using confocal microscopy should be 
performed to verify MLCK is responsible for myosin II activation.  For example, myosin 
IIA and GLUT4 proteins can be observed at different time points to determine exactly 
when myosin II associates with GLUT4 vesicles. 
This study also found that myosin II-mediated cortical actin contraction is 
necessary for proper GLUT4 vesicle fusion as well as the intrinsic activity of GLUT4.  In 
both instances, MLCK activated myosin II via phosphorylation of myosin II RLC. 
In addition, our study is the first to demonstrate the dual role that myosin II plays 
in GLUT4-mediated glucose uptake.  Our study suggests that the myosin II-mediated 
actin contraction is necessary to allow GLUT4 vesicles to fuse with the plasma 
membrane.  We also implicate myosin II-mediated actin contraction as a terminal insulin 
signaling event for GLUT4 activation.  
Taken together, our findings indicate the necessary role myosin II has on insulin-
stimulated glucose uptake.  Any impairment of myosin II activity or activation can cause 
detrimental effects during GLUT4-mediated glucose uptake.  Continued research is 
needed to further examine the role and activation of myosin II in GLUT4-mediated 
glucose uptake.  A thorough understanding of these processes can lead to practical 
innovations to treat individuals suffering from decreased insulin sensitivity and glucose 
uptake. 
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